Form 8-K - Current report:
SEC Accession No. 0001628280-21-008486
Filing Date
2021-04-30
Accepted
2021-04-30 17:15:00
Documents
1
Period of Report
2021-04-30
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K aapril2021annualshareholde.htm 8-K 34358
  Complete submission text file 0001628280-21-008486.txt   35426
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 21879681
SIC: 2834 Pharmaceutical Preparations